22 The development of a successful vaccine against HIV-1 likely requires 23 immunogens that elicit both broadly neutralizing antibodies against envelope 24 spikes and T cell responses that recognize multiple viral proteins. HIV-1 virus like 25 particles (VLP), because they display authentic envelope spikes on the particle 26 surface, may be developed into such immunogens. However, in one way or...
